NYSE · Pharmaceuticals
Novo Nordisk A/S (NVO)
Novo Nordisk is a global pharmaceutical company best known for diabetes and obesity medicines based on GLP-1 therapies. Founded in 1923 and headquartered in Bagsværd, Denmark, Novo Nordisk A/S employs approximately 77,000 people.
Quote currency: USD. Market data may be delayed and may differ from current market levels.
Price$42.53
Change-2.12%
Market cap144.39bn
P/E ratio11.40
Analyst consensusHold
Price target$47.07
Next earningsUnavailable
Dividend yield2.81%
Company profile
Headquarters
Bagsværd, Denmark
Founded
1923
Employees
77,000
Related coverage
No explicitly linked editorial coverage is currently associated with this company page.